medmix' Shareholders Approve All Proposals at Annual General Meeting 2026

Q: What dividend did medmix (MDMXF) announce at the AGM on April 16, 2026?

The company announced an ordinary dividend of CHF 0.10 per share . According to medmix, the dividend will be paid out on April 22, 2026 , as approved by shareholders at the AGM.

Q: When will medmix (MDMXF) pay the CHF 0.10 dividend approved at the AGM?

medmix will pay the approved ordinary dividend on April 22, 2026 . According to medmix, shareholders approved the appropriation of the annual result and the specified payment date at the AGM.

Rhea-AI Impact

(Moderate)

Rhea-AI Sentiment

(Very Positive)

Rhea-AI Summary

medmix (OTC:MDMXF) shareholders approved all Board proposals at the Annual General Meeting on April 16, 2026. The Annual Report 2025, consolidated financial statements, Sustainability Report and appropriation of result were approved. An ordinary dividend of CHF 0.10 per share will be paid on April 22, 2026.

Rob ten Hoedt was re-elected as Chairman, KPMG was confirmed as auditor, and Proxy Voting Services GmbH was re-elected as independent proxy. AGM minutes will be published within the statutory period on the company website.

Positive

Ordinary dividend of CHF 0.10 per share payable on April 22, 2026
Approval of Annual Report 2025 and consolidated financial statements
Re-election of Rob ten Hoedt as Chairman of the Board
Confirmation of KPMG as auditor and re-election of independent proxy

Negative

None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

04/16/2026 - 08:37 AM

medmix AG
Neuhofstrasse 20
CH-6430 Baar
communications@medmix.com
www.medmix.swiss

DOWNLOAD MEDIA RELEASE

MEDIA RELEASE

April 16, 2026

medmix’ Shareholders Approve All Proposals at Annual General Meeting 2026

At today’s annual general meeting (AGM) of medmix Ltd., shareholders approved all proposals of the Board of Directors. medmix will pay an ordinary dividend of CHF 0.10 per share.

Baar, Switzerland--(Newsfile Corp. - April 16, 2026) - medmix' shareholders approved all proposals of the company’s Board of Directors at its AGM 2026. The shareholders approved the Annual Report 2025, including the business review, the financial statements of medmix Ltd, the consolidated financial statements 2025 as well as the appropriation of the annual result and the Sustainability Report.

An ordinary dividend of CHF 0.10 per share will be paid out on April 22, 2026. In a consultative vote, the shareholders approved the compensation report of medmix. Discharge was granted to all members of the Board of Directors and of the Executive Committee. The remuneration limits for the Board of Directors for the period from AGM 2026 to AGM 2027, and for the Executive Committee for the financial year 2027, were approved as well.

Rob ten Hoedt was re-elected as Chairman of the Board of Directors, and the shareholders confirmed all members of the Board and of the Nomination & Remuneration Committee. KPMG was confirmed as auditor and Proxy Voting Services GmbH was re-elected as the independent proxy.

The minutes of the AGM 2026 will be published within the statutory period on www.medmix.swiss.

Inquiries

Investor Relations: investorrelations@medmix.com

Media Relations: communications@medmix.com

Key dates in 2026

July 23, 2026

Half-year results 2026

About medmix

medmix is a global leader in high-precision delivery devices, with leading positions in healthcare, consumer and industrial end-markets. Our customers benefit from a dedication to innovation and technological advancement that has resulted in over 900 active patents. Our 14 production sites worldwide together with our highly motivated and experienced team of nearly 2’700 employees provide our customers with uncompromising quality, proximity, and agility. medmix is headquartered in Baar, Switzerland. Our shares are traded on the SIX Swiss Exchange (SIX: MEDX). www.medmix.swiss.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/292855

FAQ

What dividend did medmix (MDMXF) announce at the AGM on April 16, 2026?

The company announced an ordinary dividend of CHF 0.10 per share. According to medmix, the dividend will be paid out on April 22, 2026, as approved by shareholders at the AGM.

When will medmix (MDMXF) pay the CHF 0.10 dividend approved at the AGM?

medmix will pay the approved ordinary dividend on April 22, 2026. According to medmix, shareholders approved the appropriation of the annual result and the specified payment date at the AGM.

Who was re-elected as chairman of medmix (MDMXF) at the April 16, 2026 AGM?

Rob ten Hoedt was re-elected as Chairman of the Board. According to medmix, shareholders confirmed all board members and the Nomination & Remuneration Committee during the AGM.

Did medmix (MDMXF) confirm its auditor at the AGM 2026 and who is it?

Yes. KPMG was confirmed as auditor for medmix. According to medmix, shareholders re-elected KPMG and also re-elected Proxy Voting Services GmbH as independent proxy at the AGM.

Where can investors find the minutes of the medmix (MDMXF) AGM 2026?

The AGM minutes will be published on the company website within the statutory period. According to medmix, the minutes will be available at www.medmix.swiss after publication.